Prediction of individual patient response to immune therapy by assessing genetic mutations, like fra

pErasmus MC and Frame Pharmaceuticals will investigate the role of frame-shift mutations in anti-tumor immune response, by evaluating frame-shift prevalence in lung tumors using genomics and bioinformatics approaches combined with clinical and treatment response data. This project will form the basis for development of novel, personalized, immunotherapy treatments for lung cancer patients./p